• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

SLA:AU

Trading has been suspended for SLA:AU

Snapshot for Solagran Ltd (SLA)

Open: - Day's Range: - Volume: 0
Previous Close: 0.0390 52wk Range: - 1-Yr Rtn: -

Stock Chart for SLA

No chart data available.
  • SLA:AU
  • 1M
  • 1Y
0.0390
Interactive SLA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SLA

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -0.0184
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 0.00
Shares Outstanding (M) 343.51
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SLA

No data available

Company Profile & Key Executives for SLA

Solagran Limited is a biotechnology company that develops and commercializes naturally biological active substances called Bioeffectives which are used for the prevention of disease, treatment of illness and promotion of health.

Vagif SoultanovChairman/FounderDarren SchliebsChief Executive Officer
Alexander KurganovExecutive DirectorNatalia ArshavskayaDir:Marketing
More Company Profile & Key Executives for SLA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil